Y. Nakata

Platelet‐derived growth factor expression in accelerated and blastic phase of chronic myelogenous leukaemia with myelofibrosis

Y. Satow, A. Kuramoto, A. Kimura, 1994, British journal of haematology.

c‐kit point mutation of extracellular domain in patients with myeloproliferative disorders

Y. Satow, O. Katoh, A. Kuramoto, 1995, British journal of haematology.

c-kit Point mutation in patients with myeloproliferative disorders.

O. Katoh, A. Kimura, H. Hyodo, 1997, Leukemia & lymphoma.

Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.

Y. Nakata, 1993, Hiroshima journal of medical sciences.

Leukemic transformation of primary myelofibrosis: immunophenotype, genotype and growth characteristics of blast cells.

Y. Satow, A. Kuramoto, A. Kimura, 1995, Leukemia & lymphoma.

Chronic lymphocytic leukemia associated with bone marrow fibrosis: Possible role of interleukin 1α in the pathogenesis

A. Kuramoto, A. Kimura, H. Hyodo, 1993, American journal of hematology.

Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis.

A. Kuramoto, A. Kimura, H. Hyodo, 1993, American journal of hematology/oncology.

1 alpha-Hydroxyvitamin D3 in the treatment of primary myelofibrosis: in vitro effect of vitamin D3 metabolites on the bone marrow fibroblasts.

A. Kuramoto, A. Kimura, H. Hyodo, 1993, International journal of hematology.